Acute pharmacological effects of temazepam, diphenhydramine, and valerian in healthy elderly subjects

Journal of Clinical Psychopharmacology

Volumn 23, Issue 3, 2003, Pages 260-268

  Glass, Jennifer R ^a,b   Sproule, Beth A ^a   Herrmann, Nathan ^a   Streiner, David ^a   Busto, Usoa E ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHENHYDRAMINE; PLACEBO; TEMAZEPAM; VALERIAN;

AGED; ANTICHOLINERGIC EFFECT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DROWSINESS; FATIGUE; FEMALE; GERIATRIC PATIENT; HEADACHE; HUMAN; HUMAN EXPERIMENT; INSOMNIA; MALE; MOOD; MULTIVARIATE ANALYSIS OF VARIANCE; NORMAL HUMAN; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; PSYCHOPHARMACOLOGY; RANDOMIZED CONTROLLED TRIAL; SEDATION; SINGLE DRUG DOSE; VISUAL ANALOG SCALE; VOLUNTEER; XEROSTOMIA;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; AREA UNDER CURVE; CROSS-OVER STUDIES; DIPHENHYDRAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; PSYCHOMOTOR PERFORMANCE; SLEEP; TEMAZEPAM; VALERIAN;

EID: 0038384131     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-200306000-00007     Document Type: Article

References (55)

1. Mellinger G, Balter MB, Uhlenhuth EH. Insomnia and its treatment: prevalence and correlates. Arch Gen Psychiatry. 1985;42:225-232.
2. National Institute of Health Conference Development Conference Statement. The treatment of sleep disorders of older people. Sleep. 1990;14:169-177.
3. Lasagna L. Over-the-counter hypnotics and chronic insomnia in the elderly. J Clin Psychopharmacol. 1995;15:383-386.
4. Simon G, VonKorff M. Prevalence, burden and treatment of insomnia in primary care. Am J Psychiatry. 1997;154:1417-1423.
5. Kupfer D, Reynolds CF. Management of insomnia. N Engl J Med. 1997;336:341-346.
6. Greenblatt D, Harmatz JS, Engelhardt N, et al. Pharmacokinetic determinants of dynamic differences among three benzodiazepine hypnotics. Arch Gen Psychiatry. 1989;46:326-332.
7. Caces M, Harford TC, Aitken SS. Prescription and non-prescription drug use: a longitudinal study. J Subst Abuse. 1998;10:115-126.
8. Kaufman D, Kelly JP, Roswenberg L, et al. Recent patterns of medication use in the ambulatory adult population of the United States. JAMA. 2002;287:111-123.
9. Katz IRPS, Bilker W, DiFilippo S, et al. Identification of medications that cause cognitive impairment in older people: the case pf oxybutynin chloride. J Am Geriatr Soc. 1998;46:8-13.
10. Meuleman J, Nelson RC, Clark LR. Evaluation of temazepam and diphenhydramine as hypnotics in a nursing home population. Drug Intell Clin Pharmacy. 1987;21:716-720.
11. Simons F, Fraser TG, Maher F, et al. Central nervous system effects of H1-receptor antagonists in the elderly. Ann Allergy Asthma Immunol. 1999;82:157-160.
12. Sands L, Katz IR, DiFilippo S, et al. Identification of drug-related cognitive impairment in older individuals. Am J Geriatr Psychiatry. 1997; 5:156-166.
13. Scavone J, Greenblatt DJ, Harmatz JS, et al. Pharmacokinetics and pharmacodynamics of diphenhydramine 25mg in young and elderly volunteers. J Clin Pharmacol. 1998;38:306-309.
14. Holbrook A, Crowther R, Lotter A, et al. The diagnosis and management of insomnia in clinical practice: a practical evidence-based approach. CMAJ. 2000;162:216-220.
15. Eisenberg D, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA. 1998;280:1569-1575.
16. Leathwood P, Chauffard F. Aqueous extract of valerian reduces latency to fall asleep in man. Planta Medica. 1985;2:144-148.
17. Lindahl O, Lindwall L. Double blind study of a valerian preparation. Pharmacol Biochem Behavior. 1989;32:1065-1066.
18. Leathwood P, Chauffard F. Quantifying the effects of mild sedatives. J Psychiat Res. 1983;17:115-122.
19. Schulz H, Stolz C, Muller J. The effect of valerian extract on sleep polygraphy in poor sleepers: a pilot study. Pharmacopsychiatry. 1994; 27:147-151.
20. United States Pharmacopeia. USP finds valerian evidence lacking. The Standard. 1998;January/February:http://www/usp.org/pubs/standard/9801_04.htm.
21. Kaplan H. When do professional psychologists need professional programmers' tools? Behavior Research Methods, Instruments and Computers. 1985;17:546-550.
22. Naranjo CA, Sellers E, Kaplen HL, et al. Acute kinetic and dynamic interactions of zimelidine with ethanol. Clin Pharm Ther. 1984;36: 654-660.
23. Wechsler D. A Manual for the Wechsler Adult Intelligence Scale (Revised). New York: Psychological Corporation; 1981.
24. Greenblatt DJ, Harmatz J, Shapiro L, et al. Sensitivity to triazolam in the elderly. N Engl J Med. 1991;324:1691-1698.
25. Busto U, Kaplan HL, Wright EC, et al. Comparative pharmacokinetic and dynamic evaluation of alprazolam sustained release, bromazepam, and lorazepam. J Clin Psychopharmacol. 2000;20:628-635.
26. Busto U, Kaplan HL, Zawertailo L, et al. Pharmacologic effects and abuse liability of bretazenil, diazepam, and alprazolam in humans. Clin Pharmacol Ther. 1994;55:451-463.
27. Zawertailo L, Busto U, Kaplan HL, et al. Comparative abuse liability of sertraline, alprazolam, and dextroamphetamine in humans. J Clin Psychopharmacol. 1995;15:117-124.
28. Kay GG, Berman B, Mockoviak SH, et al. Initial and steady-state effects of diphenhydramine and loratadine on sedation, cognition, mood, and psychomotor performance. Arch Intern Med 1997;157: 2350-2356.
29. Berlinger W, Goldberg MJ, Spector R, et al. Diphenhydramine: kinetics and psychomotor effects in elderly women. Clin Pharmacol Ther. 1982;32:387-391.
30. Lines C, Traub M, Raskin S, et al. Lack of sedative and cognitive effects of diphenhydramine and cyclobenzaprine in elderly volunteers. J Psychopharmacol. 1997;11:325-329.
31. Leathwood P, Chauffard F, Heck E, et al. Aqueous extract of valerian root improves sleep quality in man. Pharmacol Biochem Behavior. 1982;17:65-71.
32. Balderer G, Borbely AA. Effect of valerian on human sleep. Psychopharmacol. 1985;87:406-409.
33. Bos R, Woerdenbag HJ, van Putten FMS, et al. Seasonal variation of the essential oil, valerenic acid and derivatives, and valeportiates in Valeriana officinalis roots and rhizomes, and the selection of plants suitable for phytomedicines. Planta Med. 1998;64:143-147.
34. Pedhazur E. Multiple Regression in Behavioral Research. 2nd ed. Fort Worth: Holt, Rinehart, & Winston; 1973.
35. Rush C, Griffiths RR. Zolpidem, triazolam, and temazepam: behavioural and subject-rated effects in normal volunteers. J Clin Psychopharmacol. 1996;16:146-157.
36. van Steveninck A, Wallnofer AE, Schoemaker RC, et al. A study of the effects of long-term use on individual sensitivity to temazepam and lorazepam in a clinical population. Br J Clin Pharmacol. 1997; 44:267-275.
37. Smith R, Divoll M, Gillespie WR, et al. Effect of subject age and gender on the pharmacokinetics of oral triazolam and temazepam. J Clin Psychopharmacol. 1983;3:172-176.
38. Divoll M, Greenblatt DJ, Harmatz JS, et al. Effect of age and gender on disposition of temazepam. J Pharmaceutical Sci. 1981;70:1104-1107.
39. Hemmeter U, Muller M, Bischof R, et al. Effect of zopiclone and temazepam on sleep EEG pardmeters, psychomotor and memory functions in healthy elderly volunteers. Psychopharmacology. 2000;147: 384-396.
40. Cook P, Huggett A, Graham-Pole R, et al. Hypnotic accumulation and hangover in elderly inpatients: a controlled double-blind study of temazepam and nitrazepam. BMJ. 1983;286:100-102.
41. Hindmarch I. A 1,4-benzodiazepine, temazepam (K 3917) its effect on some psychological parameters of sleep and behaviour. Arzneimittel-Forschung. 1975;25:1836-9.
42. Roth T, Piccione P, Salis P, et al. Effects of temazepam, flurazepam, and quinalbarbitone on sleep: psychomotor and cognitive function. Br J Clin Pharmacol. 1979;8:47S-54S.
43. Roehrs T, Vogel G, Sterling W, et al. Dose effects of temazepam in transient insomnia. Arzmeim-Forsch/Drug Res. 1990;40:859-62.
44. Tharion W, McMenemy DJ, Rauch TM. Antihistamine effects on the central nervous system, cognitive performance and subjective states. Neuropsychobiology. 1994;29:97-104.
45. Curran H, Pooviboonsuk P, Dalton JA, et al. Differentiating the effects of centrally acting drugs on arousal and memory: an eventrelated potential study of scopolamine, lorazepam, and diphenhydramine. Psychopharmacol. 1998;135:27-36.
46. Saletu B, Grunberger J, Anderer P, et al. Pharmacodynamic studies of a combination of lorazepam and diphenhydramine and its single components: EEG brain mapping and safety evaluation. Curr Ther Res. 1988;44:909-937.
47. Gengo F, Gabos C, Miller JK. The pharmacodynamics of diphenhydramine-induced drowsiness and changes in mental performance. Clin Pharmacol Ther. 1989;45:15-21.
48. Teutsch G. Hypnotic efficacy of diphenhydramine, methapyrilene, and pentobarbital. Clin Pharmacol Ther. 1975; 17:295-301.
49. Witek T, Canestrari DA, Miller RD, et al. Characterization of daytime sleepiness and psychomotor performance following H1 receptor antagonists. Ann Allergy Asthma Immunol. 1995;74:419-426.
50. Schmitz M, Jackel M. Comparative study for assessing quality of life of patients with exogenous sleep disorders (temporary sleep onset and sleep interruption disorders) treated with hops-valerian preparation and a benzodiazepine drug [abstract in English]. Wien Med Wochenschr. 1998;148:291-298.
51. Wheatley D. Kava and Valerian in the treatment of stress-induced insomnia. Phytother Res. 2001;15:549-551.
52. Kuhlmann J, Berger W, Podzuweit H, et al. The influence of valerian treatment on "reaction time, alertness and concentration" in volunteers. Pharmacopsychiatry. 1999;32:235-241.
53. Donath F, Quispe K, Diefenbach Maurer A, et al. Critical evaluation of the effect of valerian extract on sleep structure and sleep quality. Pharmacopsychiatry. 2000;33:47-53.
54. Schulz V, Hansel R, Tyler VE. Rational Phytotherapy: A Physician's Guide to Herbal Medicine. 3rd ed. Berlin: Springer-Verlag; 1998.
55. Blumenthal M. EAPC files petition for OTC drug use for valerian and ginger. HerbalGram. 1995;35:19-21;63.